Cadila Pharmaceuticals Ltd. signs MoU with the Government of Gujarat. Pharma giant will overall invest Rs. 1000 crores in a span of three years until 2025 in different ongoing projects
Ayush Ministry signs MoU with Ministry of Rural Development to empower the rural youth Delhi: Ministry of Ayush and Ministry of Rural Development, Government of India signed an MoU to
Ahmedabad: Eight children with scoliosis, an uncommon condition characterized by the lateral curvature of the spine, were operated upon at GCS Hospital in Ahmedabad in collaboration with a team of
Heart failure treatment becomes more affordable with Glenmark launching the Sacubitril + Valsartan tablets in India. This drug helps reduce the risk of cardiovascular related deaths and hospitalizations. Mumbai January
Cadila Pharmaceuticals’s Raj Prakash Vyas honoured with Award of Excellence by Governor of Maharashtra for his Lifetime Contribution to Industry. Mumbai: Raj Prakash Vyas, President of Corporate Affairs at Cadila
Glenmark Pharmaceuticals launches Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) Single-Dose Vials and 2.5 mg/10 mL (0.25 mg/mL) Multi-Dose Vials India/USA; January 11, 2023 – Glenmark Pharmaceuticals Inc., USA (Glenmark) is
Swasthya Diabetes’s Project Krishna to help children manage Type 1 Diabetes. Over 400 children suffering from Type 1 diabetes will be mentored by medical students for a year to help them
HealthOK launches lemon flavored tablet with new packaging of the product. The new packaging is aimed at elevating the overall health benefit of the supplement. New Delhi, 30th December 2022:
Selenium in Health and Diseases, the book edited by Dr. Muhammed Majeed, Founder and Chairman of Sami-Sabinsa Group, delves into the chemistry, biochemistry, and biology of the selenium element in
